INSPECS Group plc Share Price
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
16:35:14 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 96.00 GBX | 0.00% |
|
0.00% | +34.27% |
| 09-10 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 09-10 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 140M 122M 115M 105M 196M 13.45B 197M 1.38B 534M 6.84B 527M 515M 22B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 96.1M 83.8M 79.13M 71.85M 135M 9.22B 135M 948M 366M 4.69B 361M 353M 15.09B | EV / Sales 2026 * |
0.36x | EV / Sales 2027 * | 0.34x |
| Free-Float |
10.73% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 03-04 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-11 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-09 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 01-27 | Form 8.3 - Inspecs Group Plc | AQ |
| 01-07 | Form 8.3 - Inspecs Group Plc | AQ |
| 1 month | -1.03% | ||
| 3 months | -4.48% | ||
| 6 months | +15.66% | ||
| Current year | +34.27% |
| 1 week | 92 |  | 100 |
| 1 month | 92 | | 100 |
| Current year | 60 | | 105 |
| 1 year | 39 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 30/11/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 09/01/2020 |
Angela Farrugia
BRD | Director/Board Member | 61 | 11/05/2020 |
Luke Johnson
BRD | Director/Board Member | 64 | 18/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/06/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 04/06/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 08/11/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +140.00% | +7.87% | 140M | |
| -1.73% | -5.05% | -49.36% | -19.85% | 73.26B | |
| +0.41% | -0.59% | -12.32% | -26.29% | 31.5B | |
| +4.01% | +3.73% | - | - | 12.81B | |
| +2.82% | +2.56% | -17.75% | -34.46% | 10.51B | |
| +1.20% | -4.61% | -9.78% | +579.73% | 2.5B | |
| +0.60% | +0.90% | -42.17% | -62.24% | 1.34B | |
| -0.85% | +5.67% | - | - | 973M | |
| -1.25% | +7.76% | +25.32% | +11.86% | 956M | |
| +1.67% | +6.24% | -37.32% | -21.29% | 892M | |
| Average | +0.69% | +0.75% | -0.42% | +54.42% | 13.49B | |
| Weighted average by Cap. | -0.22% | -2.57% | -35.19% | -10.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 233M 220M 200M 374M 25.64B 376M 2.64B 1.02B 13.03B 1B 981M 41.94B | 277M 241M 228M 207M 388M 26.55B 389M 2.73B 1.05B 13.5B 1.04B 1.02B 43.44B |
| Net income | - | - |
| Net Debt | -44.08M -38.43M -36.29M -32.95M -61.74M -4.23B -62M -435M -168M -2.15B -166M -162M -6.92B | -45.44M -39.62M -37.41M -33.97M -63.65M -4.36B -63.92M -448M -173M -2.22B -171M -167M -7.13B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | GBX 96.00 | 0.00% | 82 |
| 17/09/26 | GBX 96.00 | 0.00% | 0 |
| 16/09/26 | GBX 96.00 | 0.00% | 1,877 |
| 15/09/26 | GBX 96.00 | 0.00% | 14,019 |
| 14/09/26 | GBX 96.00 | 0.00% | 0 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.284USD
Average target price
0.8180USD
Spread / Average Target
-36.29%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
